For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Tonix Pharmaceuticals Holding Corp’s stock clocked out at $0.16, up 1.91% from its previous closing price of $0.16. In other words, the price has increased by $1.91 from its previous closing price. On the day, 1.08 million shares were traded. TNXP stock price reached its highest trading level at $0.163 during the session, while it also had its lowest trading level at $0.15.
Ratios:
To gain a deeper understanding of TNXP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 15287008 and an Enterprise Value of -1616462. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.74 while its Price-to-Book (P/B) ratio in mrq is 0.09. Its current Enterprise Value per Revenue stands at -0.208 whereas that against EBITDA is 0.014.
Stock Price History:
Over the past 52 weeks, TNXP has reached a high of $3.31, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -46.43%, while the 200-Day Moving Average is calculated to be -74.40%.
Shares Statistics:
It appears that TNXP traded 2.19M shares on average per day over the past three months and 3111110 shares per day over the past ten days. A total of 84.49M shares are outstanding, with a floating share count of 84.49M. Insiders hold about 0.01% of the company’s shares, while institutions hold 19.88% stake in the company. Shares short for TNXP as of 1711584000 were 1253951 with a Short Ratio of 0.57, compared to 1709164800 on 616239. Therefore, it implies a Short% of Shares Outstanding of 1253951 and a Short% of Float of 1.7000000000000002.
Earnings Estimates
The current assessment of Tonix Pharmaceuticals Holding Corp (TNXP) involves the perspectives of Tonix Pharmaceuticals Holding C analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $24.72, with high estimates of $1.58 and low estimates of $14.02.
